Insider Transactions in Q2 2022 at Altimmune, Inc. (ALT)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,007
-1.07%
|
$33,077
$11.7 P/Share
|
|
Jun 29
2022
|
M Scot Roberts Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,462
-23.58%
|
$65,544
$12.0 P/Share
|
|
Jun 29
2022
|
M Scot Roberts Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,462
+19.08%
|
$10,924
$2.6 P/Share
|
|
Jun 27
2022
|
Diane Jorkasky Director |
SELL
Open market or private sale
|
Direct |
17,610
-100.0%
|
$193,710
$11.75 P/Share
|
|
Jun 27
2022
|
Diane Jorkasky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,610
+50.0%
|
$52,830
$3.15 P/Share
|
|
Jun 27
2022
|
M Scot Roberts Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
37,352
-67.85%
|
$448,224
$12.0 P/Share
|
|
Jun 27
2022
|
M Scot Roberts Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,352
+27.38%
|
$74,704
$2.26 P/Share
|
|
Jun 20
2022
|
Klaus Schafer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
279
+1.01%
|
$558
$2.4 P/Share
|
|
Jun 15
2022
|
David Drutz Director |
BUY
Open market or private purchase
|
Direct |
1,000
+4.76%
|
$8,000
$8.0 P/Share
|
|
May 30
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,008
-1.06%
|
$15,040
$5.03 P/Share
|
|
May 24
2022
|
David Drutz Director |
BUY
Open market or private purchase
|
Direct |
1,200
+5.94%
|
$4,800
$4.5 P/Share
|
|
Apr 30
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,008
-1.05%
|
$12,032
$4.52 P/Share
|